MedTrace Logo

Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis

NCT03839069 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-02-15

No results posted yet for this study

Summary

This is a prospective study that aimed to observe the therapeutic effects of minor salivary gland transplantation for cicatrizing conjunctivitis patients.

Conditions

  • Cicatrizing Conjunctivitis
  • Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
  • Sjogren Syndrome
  • Mucous Membrane Pemphigoid
  • Chronic Graft Versus Host Disease
  • Chemical Burn to Eye

Interventions

PROCEDURE

minor salivary gland transplantation

The investigators will harvest the autologous labial salivary gland tissue and transplant to the upper and lower conjunctival fornix of the lesion eye.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Hsiao-Sang Chu, MD, MS · Department of Ophthalmology, NTUH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-12-31
Completion
2021-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03839069 on ClinicalTrials.gov